
Application of transitional provisions for certification of class D in vitro diagnostic medical devices according to Regulation 2017/746
The Medical Device Coordination group has released a questions and answers document regarding the transitional period lasting untill May 2022 when the IVDR becomes fully applicable.
The document highlights the possible course of action for notified bodies in the absence of expert panels and EU reference laboratory (EURL), which might be necessary to involve for certifying a class D in vitro diagnostic medical device. Since according to the IVDR (Regulation (EU) 2017/746 on in vitro diagnostic medical devices), as part of conformity assessment of class D in vitro diagnostic medical devices (IVDs), the manufacturer must submit an application to a notified body. In addition to the assessment by the notified body, under certain conditions particular elements may be reviewed by an expert panel and/or tested by an EU reference laboratory (EURL).
The document provides the following Q&As:
Q1. During the transition period, may notified bodies accept applications from manufacturers for certification of class D IVDs, and issue the corresponding certificates, if the IVD expert panel is not yet operational?
Notified bodies may accept and begin the assessment of applications for class D IVDs. However, the notified bodies may not issue the certificate before the expert panel is operational and, for the devices that require consultation of the panel, before the panel has provided its views (see also Q2 and Q3).
Q2. For devices to which this requirement is applicable, when must the notified body submit the performance evaluation report of the manufacturer to the expert panel?
According to IVDR Art 48(6), “the notified body shall provide the performance evaluation report of the manufacturer to the expert panel within five days of receiving it from the manufacturer”. If the panel is not yet operational, the notified body should submit the performance evaluation report of the manufacturer within five days of the panel becoming operational.
Q3. How should the notified body determine whether the device will have to undergo consultation of the expert panel prior to issuing the certificate?
According to IVDR Article 48 (6), “where no CS are available for class D devices and where it is also the first certification for that type of device, the notified body shall consult the relevant experts referred to in Article 106 of Regulation (EU) 2017/745 on the performance evaluation report of the manufacturer”. MDCG guidance is in preparation on what constitutes a “type of device”, as well as on As announced on the process that the notified bodies should follow to determine whether a given certification is the first one for that type.
Q4. When can the notified body expect to receive the views of the expert panel?
According to IVDR Article 48(6), “The experts shall provide their views to the notified body within the deadline for delivery of the scientific opinion by the EU reference laboratory”. If no EU reference laboratory (EURL) is designated for the device in question, the expert panel should provide its views within 60 days, in line with the time available for the EURL to issue its opinion according to Section 4.9 of Annex IX and Section 3 (j) of Annex X.
Q5. During the transition period, may notified bodies accept applications from manufacturers for certification of a class D IVD, and issue the corresponding certificate(s), if an EURL is not designated for that device?
During the transition period, as long as no EURL has yet been designated for that specific device, category or group of device, the notified bodies may accept applications for a class D IVD and issue the corresponding certificate(s).
Q6. What will happen to devices certified under the IVDR in the absence of an EURL if an EURL is designated for the corresponding scope at a later time point?
The certificate will remain valid until its expiry date established by the notified body and according to the IVDR. On sample or batch testing, the notified body and manufacturer should follow the EURL related provisions of Section 4.12 of Annex IX or Section 5 of Annex XI from the time that the EURL becomes operational. For performance verification, the notified body should follow the EURL-related provisions of Section 4.9 of Annex IX or Section 3 (j) of Annex X at the time of the re-certification in line with Section 4.11 (f) of Annex VII. So, the procedure set out in paragraph 5 of Article 48 involving an EURL will be applied at the time of the re-certification.
Get the original document here: Click
Don’t forget to check out our Webinar offer for April and June
Latest posts
-
21 November, 2023 Blog Pharma
New Alternative Methodologies (NAM): a new approach
-
14 November, 2023 Chemical
REACH Restriction on Microplastics